Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01344330 · ClinicalTrials.gov registry record
Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients
A clinical trial, sponsored by Texas A&M University.
- Completed
- Registry status
- 108
- Enrollment target
NCT01344330 is a clinical trial that has completed, run by Texas A&M University. The registered enrollment target is 108 participants.
The verdict
NCT01344330 has completed, sponsored by Texas A&M University.
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
Study Summary
This research study will assess cruciferous vegetable intake in patients presenting for screening colonoscopy and correlate intake with histone status and histone deacetylace (HDAC) expression in tissue biopsy specimens and peripheral blood mononuclear cells (PBMCs). The investigators will also measure sulforaphane (SFN) metabolites in blood as a biomarker of cruciferous vegetable intake.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2012-01 |
| Est. Completion | 2017-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01344330
The ClinicalTrials.gov registry entry for NCT01344330 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas A&M University, which has 95 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01344330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01344330 about?
NCT01344330 is a clinical study titled "Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients". This research study will assess cruciferous vegetable intake in patients presenting for screening colonoscopy and correlate intake with histone status and histone deacetylace (HDAC) expression in tissue biopsy specimens and peripheral blood mononuclear cells (PBMCs). The investigators will also meas...
What is the current status of trial NCT01344330?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2012-01. Estimated completion is 2017-12.
Who is sponsoring clinical trial NCT01344330?
This trial is sponsored by Texas A&M University, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.